We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
260 hedge funds and large institutions have $7.73B invested in Fate Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 90 increasing their positions, 90 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
44% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 36
5% more funds holding
Funds holding: 248 → 260 (+12)
0.42% more ownership
Funds ownership: 99.57% → 99.98% (+0.42%)
0% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 90
3% less capital invested
Capital invested by funds: $7.94B → $7.73B (-$215M)
10% less call options, than puts
Call options by funds: $23.3M | Put options by funds: $25.8M
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
260
Holders Change
+12
Holders Change %
+4.84%
% of All Funds
4.57%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.21%
New
52
Increased
90
Reduced
90
Closed
36
Calls
$23.3M
Puts
$25.8M
Net Calls
-$2.53M
Net Calls Change
-$232K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$350M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$82.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$69.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.8M |
| 5 |
BlackRock
New York
|
+$47.1M |
